SAN ANTONIO (October 3, 2014) — Women at risk for breast, ovarian and other reproductive cancers can easily find a bewildering — and sometimes frightening — array of information.
Will chemotherapy damage a young woman’s ability to have children? Can a woman who’s had breast cancer take hormone therapy to relieve menopause symptoms?
Putting it all in perspective, two female physicians are teaming up to provide a free lecture and Q&A on the topics at the Cancer Therapy & Research Center on Thursday, Oct. 9.
Jennifer Knudtson, M.D., a reproductive endocrinology and infertility fellow in the Department of Obstetrics and Gynecology in the School of Medicine at the UT Health Science Center, and Georgia McCann, M.D., a CTRC oncologist and clinical assistant professor in the same department, will lay out the latest treatment options and the issue of fertility preservation for younger women. They will also explain hormone treatment options, explaining the concerns that arose with the Women’s Health Initiative data and breast cancer rates, as well as who is really at risk and what other options are available.
The lecture, which is free and open to the public, will be Thursday, Oct. 9 from 6 to 7 p.m. on the fourth floor of the CTRC’s Grossman Building, 7979 Wurzbach Rd., San Antonio. For more information call (210) 450-1152. It will be streamed live online at www.CTRC.net/LIVE.
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.